S'abonner

Risk factors and associated outcomes of hospital readmission in COPD: A systematic review - 12/11/20

Doi : 10.1016/j.rmed.2020.105988 
Chidiamara M. Njoku a, , Jaber S. Alqahtani b, c, Barbara C. Wimmer a, Gregory M. Peterson a, Leigh Kinsman d, John R. Hurst b, Bonnie J. Bereznicki e
a School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia 
b UCL Respiratory, University College London, London, UK 
c Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia 
d School of Nursing and Midwifery, University of Newcastle, Port Macquarie, New South Wales, Australia 
e School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia 

Corresponding author. School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Private Bag 26, Hobart, TAS, 7001,Australia.School of Pharmacy and PharmacologyCollege of Health and MedicineUniversity of TasmaniaPrivate Bag 26HobartTAS7001Australia

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a leading cause of unplanned readmission. There is need to identify risk factors for, and strategies to prevent readmission in patients with COPD.

Aim

To systematically review and summarise the prevalence, risk factors and outcomes associated with rehospitalisation due to COPD exacerbation.

Method

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Five databases were searched for relevant studies.

Results

Fifty-seven studies from 30 countries met the inclusion criteria. The prevalence of COPD-related readmission varied from 2.6 to 82.2% at 30 days, 11.8–44.8% at 31–90 days, 17.9–63.0% at 6 months, and 25.0–87.0% at 12 months post-discharge. There were differences in the reported factors associated with readmissions, which may reflect variations in the local context, such as the availability of community-based services to care for exacerbations of COPD. Hospitalisation in the previous year prior to index admission was the key predictor of COPD-related readmission. Comorbidities (in particular asthma), living in a deprived area and living in or discharge to a nursing home were also associated with readmission. Relative to those without readmissions, readmitted patients had higher in-hospital mortality rates, shorter long-term survival, poorer quality of life, longer hospital stay, increased recurrence of subsequent readmissions, and accounted for greater healthcare costs.

Conclusions

Hospitalisation in the previous year was the principal risk factor for COPD-related readmissions. Variation in the prevalence and the reported factors associated with COPD-related readmission indicate that risk factors cannot be generalised, and interventions should be tailored to the local healthcare environment.

Le texte complet de cet article est disponible en PDF.

Highlights

Hospitalisation in the previous year is key predictor of COPD-related readmission.
COPD-related readmissions are associated with higher in-hospital mortality rates.
Prevalence of COPD readmission varies between countries.
Determinants of COPD readmission are not readily generalisable.
Interventions should be tailored to the local healthcare environment.

Le texte complet de cet article est disponible en PDF.

Keywords : COPD, Readmission, Risk factors, Consequences

Abbreviations : 6MWD, BMI, BODE, CCI, COPD, CRP, ECOPD, EKG, FEV1, FVC, GOLD, HADS, ICS, IHM, LABA, LOS, LTOT, MRC, NI, PaCO2, SGRQ, WBC


Plan


© 2020  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 173

Article 105988- novembre 2020 Retour au numéro
Article précédent Article précédent
  • Are there differences in muscular activation to maintain balance between individuals with chronic obstructive pulmonary disease and controls?
  • Larissa Araújo de Castro, Andrea Akemi Morita, Walter Sepúlveda-Loyola, Rubens Alexandre da Silva, Fabio Pitta, Eddy Krueger, Vanessa Suziane Probst
| Article suivant Article suivant
  • Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases
  • Jiao Liu, Lidi Zhang, Yizhu Chen, Zhixiong Wu, Xuan Dong, Jean-Louis Teboul, Sheng Zhang, Xiaofei Ye, Yongan Liu, Tao Wang, Hangxiang Du, Wenzhe Li, Dechang Chen

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.